Latest Insider Transactions at Amneal Pharmaceuticals, Inc. (AMRX)
This section provides a real-time view of insider transactions for Amneal Pharmaceuticals, Inc. (AMRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Amneal Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Amneal Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 22
2024
|
John Kiely Director |
SELL
Open market or private sale
|
Direct |
17,058
-6.0%
|
$136,464
$8.38 P/Share
|
Nov 22
2024
|
John Kiely Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,506
+9.11%
|
$114,024
$4.76 P/Share
|
Nov 22
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
33,229
-38.36%
|
$265,832
$8.34 P/Share
|
Nov 21
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
6,771
-7.25%
|
$54,168
$8.41 P/Share
|
Nov 21
2024
|
Jason B. Daly SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,665
-100.0%
|
$109,320
$8.4 P/Share
|
Nov 15
2024
|
Jason B. Daly SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
43,657
-76.16%
|
$349,256
$8.61 P/Share
|
Aug 15
2024
|
Andrew S Boyer Executive Vice President |
SELL
Open market or private sale
|
Direct |
40,225
-13.55%
|
$281,575
$7.85 P/Share
|
Aug 14
2024
|
Nikita Shah Executive Vice President |
SELL
Open market or private sale
|
Direct |
100,000
-25.53%
|
$700,000
$7.75 P/Share
|
Aug 14
2024
|
Andrew S Boyer Executive Vice President |
SELL
Open market or private sale
|
Direct |
22,486
-7.04%
|
$157,402
$7.81 P/Share
|
May 17
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
23,447
-20.07%
|
$140,682
$6.73 P/Share
|
May 16
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
14,553
-11.08%
|
$87,318
$6.76 P/Share
|
May 10
2024
|
Deborah M. Autor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+36.78%
|
-
|
May 10
2024
|
Emily Peterson Alva Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.36%
|
-
|
May 10
2024
|
Shlomo Yanai Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.73%
|
-
|
May 10
2024
|
Ted C Nark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+20.27%
|
-
|
May 10
2024
|
J Kevin Buchi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+22.58%
|
-
|
May 10
2024
|
Jeffrey P. George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+22.1%
|
-
|
May 10
2024
|
John Kiely Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.02%
|
-
|
May 10
2024
|
Paul M Meister Director |
BUY
Exercise of conversion of derivative security
|
Direct |
107,034
+12.82%
|
-
|
May 10
2024
|
Gautam Patel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+3.6%
|
-
|
Mar 12
2024
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,790
-5.52%
|
$153,950
$5.31 P/Share
|
Mar 12
2024
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
87,720
+13.58%
|
-
|
Mar 03
2024
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,023
-3.82%
|
$180,115
$5.47 P/Share
|
Mar 03
2024
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
102,629
+9.81%
|
-
|
Mar 03
2024
|
Jason B. Daly SVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,030
-17.62%
|
$90,150
$5.47 P/Share
|
Mar 03
2024
|
Jason B. Daly SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,871
+36.9%
|
-
|
Mar 03
2024
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
44,562
-6.74%
|
$222,810
$5.47 P/Share
|
Mar 03
2024
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
88,945
+11.86%
|
-
|
Mar 03
2024
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
41,135
-5.12%
|
$205,675
$5.47 P/Share
|
Mar 03
2024
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
82,103
+9.26%
|
-
|
Mar 01
2024
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,257
-3.18%
|
$66,285
$5.47 P/Share
|
Mar 01
2024
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,197
+7.99%
|
-
|
Mar 01
2024
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,219
-5.57%
|
$81,095
$5.47 P/Share
|
Mar 01
2024
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,371
+9.72%
|
-
|
Mar 01
2024
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
15,181
-4.15%
|
$75,905
$5.47 P/Share
|
Mar 01
2024
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
28,957
+7.33%
|
-
|
Feb 27
2024
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,670
-5.25%
|
$93,350
$5.71 P/Share
|
Feb 27
2024
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,620
+9.11%
|
-
|
Feb 27
2024
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,556
-5.99%
|
$82,780
$5.71 P/Share
|
Feb 27
2024
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,663
+10.28%
|
-
|
Jan 01
2024
|
Gautam Patel Director |
BUY
Bona fide gift
|
Direct |
1,598,115
+44.76%
|
-
|
Jan 01
2024
|
Gautam Patel Director |
SELL
Other acquisition or disposition
|
Direct |
33,458,067
-98.89%
|
-
|
Nov 07
2023
|
Chintu Patel Co-CEO |
BUY
Other acquisition or disposition
|
Indirect |
24,753,252
+50.0%
|
-
|
Nov 07
2023
|
Chirag K. Patel President & Co-CEO |
BUY
Other acquisition or disposition
|
Indirect |
21,269,420
+50.0%
|
-
|
Nov 07
2023
|
Dipan Patel |
BUY
Other acquisition or disposition
|
Indirect |
26,905,073
+50.0%
|
-
|
Nov 07
2023
|
Gautam Patel Director |
BUY
Other acquisition or disposition
|
Indirect |
17,497,336
+36.54%
|
-
|
Nov 07
2023
|
Tushar Bhikhubhai Patel > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
53,578,209
+50.0%
|
-
|
Aug 11
2023
|
Andrew S Boyer Executive Vice President |
SELL
Open market or private sale
|
Direct |
29,302
-10.69%
|
$117,208
$4.13 P/Share
|
Jul 30
2023
|
Deborah M. Autor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
54,949
+50.0%
|
-
|
Jun 30
2023
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,571
-4.05%
|
$34,713
$3.1 P/Share
|